doi: 10.1093/bioinformatics/btp134.
Epub 2009 Mar 20.
The calibrated population resistance tool: standardized genotypic estimation of transmitted HIV-1 drug resistance
Affiliations
- PMID: 19304876
- PMCID: PMC2672634
- DOI: 10.1093/bioinformatics/btp134
Item in Clipboard
The calibrated population resistance tool: standardized genotypic estimation of transmitted HIV-1 drug resistance
Bioinformatics.
.
Abstract
The calibrated population resistance (CPR) tool is a web-accessible program for performing standardized genotypic estimation of transmitted HIV-1 drug resistance. The program is linked to the Stanford HIV drug resistance database and can additionally perform viral genotyping and algorithmic estimation of resistance to specific antiretroviral drugs.
Availability: http://cpr.stanford.edu/cpr/index.html.
Similar articles
-
Construction, training and clinical validation of an interpretation system for genotypic HIV-1 drug resistance based on fuzzy rules revised by virological outcomes.Antivir Ther. 2004 Aug;9(4):583-93. Antivir Ther. 2004. PMID: 15456090
-
Analysis of discrepancies in the interpretation of antiretroviral drug resistance results in HIV-1 infected patients of Basque Country, Spain.J Clin Virol. 2005 Jul;33(3):224-9. doi: 10.1016/j.jcv.2004.06.014. Epub 2005 Jan 12. J Clin Virol. 2005. PMID: 15911444
-
Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Verh K Acad Geneeskd Belg. 2001. PMID: 11813503 Review.
-
Discrepant results in the interpretation of HIV-1 drug-resistance genotypic data among widely used algorithms.HIV Med. 2003 Jan;4(1):72-8. doi: 10.1046/j.1468-1293.2003.00131.x. HIV Med. 2003. PMID: 12534963
-
Consensus drug resistance mutations for epidemiological surveillance: basic principles and potential controversies.Antivir Ther. 2008;13 Suppl 2(0 2):59-68. Antivir Ther. 2008. PMID: 18575192 Free PMC article. Review.
Cited by
-
Crystallographic study of multi-drug resistant HIV-1 protease lopinavir complex: mechanism of drug recognition and resistance.Biochem Biophys Res Commun. 2013 Jul 26;437(2):199-204. doi: 10.1016/j.bbrc.2013.06.027. Epub 2013 Jun 18. Biochem Biophys Res Commun. 2013. PMID: 23792096 Free PMC article.
-
Proposal of pharmacophore model for HIV reverse transcriptase inhibitors: Combined mutational effect analysis, molecular dynamics, molecular docking and pharmacophore modeling study.Int J Immunopathol Pharmacol. 2024 Jan-Dec;38:3946320241231465. doi: 10.1177/03946320241231465. Int J Immunopathol Pharmacol. 2024. PMID: 38296818 Free PMC article.
-
Increase of transmitted drug resistance among HIV-infected sub-Saharan Africans residing in Spain in contrast to the native population.PLoS One. 2011;6(10):e26757. doi: 10.1371/journal.pone.0026757. Epub 2011 Oct 25. PLoS One. 2011. PMID: 22046345 Free PMC article.
-
Profile of the HIV epidemic in Cape Verde: molecular epidemiology and drug resistance mutations among HIV-1 and HIV-2 infected patients from distinct islands of the archipelago.PLoS One. 2014 Apr 24;9(4):e96201. doi: 10.1371/journal.pone.0096201. eCollection 2014. PLoS One. 2014. PMID: 24763617 Free PMC article.
-
Prevalence of Transmitted HIV Drug Resistance Among Recently Infected Persons in San Diego, CA 1996-2013.J Acquir Immune Defic Syndr. 2016 Feb 1;71(2):228-36. doi: 10.1097/QAI.0000000000000831. J Acquir Immune Defic Syndr. 2016. PMID: 26413846 Free PMC article.
References
-
- Bennett DE, et al. The World Health Organization's global strategy for prevention and assessment of HIV drug resistance. Antivir. Ther. 2008a;13(Suppl. 2):1–13. - PubMed
-
- Bennett DE, et al. Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment. Antivir. Ther. 2008b;13(Suppl. 2):25–36. - PubMed
-
- Bertagnolio S, et al. HIV-1 drug resistance surveillance using dried whole blood spots. Antivir. Ther. 2007;12:107–113. - PubMed
-
- Gilks CF, et al. The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings. Lancet. 2006;368:505–510. - PubMed
